We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
California officials need to keep better track of the money that drugmakers owe as rebates on drugs covered by Medicaid, according to the HHS Office of Inspector General (OIG).